Apogem Capital’s Shattuck Labs STTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-78,757
Closed -$213K 107
2022
Q3
$213K Buy
78,757
+2,712
+4% +$10.2K 0.21% 116
2022
Q2
$309K Buy
76,045
+17,206
+29% +$62.3K 0.28% 108
2022
Q1
$251K Buy
58,839
+39,294
+201% +$223K 0.17% 140
2021
Q4
$166K Buy
19,545
+6,556
+50% +$90.3K 0.11% 163
2021
Q3
$265K Buy
+12,989
New +$278K 0.17% 157

Other funds holding STTK

Apogem Capital's STTK Position: Q4 2022 in Review

Apogem Capital sold out of Shattuck Labs (STTK) in Q4 2022, closing a stake of 78,757 shares — an estimated $213K sold.

Apogem Capital first reported a position in STTK in Q3 2021 and held it in 5 quarters. The position peaked at $309K in Q2 2022. 48 funds tracked by Wall St. Rank hold STTK as of Q4 2022.

  • Apogem Capital reported no remaining Shattuck Labs position as of Q4 2022 after selling out during the quarter.
  • Apogem Capital sold 78,757 Shattuck Labs shares in Q4 2022, an estimated $213K.
  • Apogem Capital first reported a position in Shattuck Labs in Q3 2021 and held it in 5 quarters.
  • Apogem Capital's Shattuck Labs position peaked at $309K in Q2 2022.
  • 48 funds tracked by Wall St. Rank held Shattuck Labs as of Q4 2022.

Based on Apogem Capital's 13F filing for Q4 2022, filed 13 Feb 2023.